Hospital-Based Colorectal Cancer Survival Trend of Different Tumor Locations from 1960s to 2000s

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Fang, Yu Jing ^a   Wu, Xiao Jun ^a   Zhao, Qian ^b   Li, Li Ren ^a   Lu, Zhen Hai ^a   Ding, Pei Rong ^a   Zhang, Rong Xin ^a   Kong, Ling Heng ^a   Wang, Fu Long ^a   Lin, Jun Zhong ^a   Chen, Gong ^a   Pan, Zhi Zhong ^a   Wan, De Sen ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHILD; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RECTUM CANCER; RISK ASSESSMENT; SCHOOL CHILD; SEX RATIO; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84884191912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073528     Document Type: Article

References (39)

1. Weitz J, Koch M, Debus J, (2005) Colorectal cancer. Lancet 365(9454):: 153-165. doi:10.1016/S0140-6736(05)17706-X.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61(2):: 69-90. doi:10.3322/caac.20107.
3. Zheng S, Shanrong C, (2003) Colorectal cancer epidemiology and prevention study in China. The Chinese-German journal of clinical oncology 2(2):72-5.
4. Yang L, Parkin DM, Ferlay J, Li L, Chen Y, (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14(1):: 243-250.
5. Zheng S, (ed.) (2006) Colorectal Tumor------- Basic Research and Clinical Practice. Beijing: People's Medical Publishing House.
6. Moore MA, Sobue T, Kuriki K, Tajima K, Tokudome S, et al. (2005) Comparison of Japanese, American-Whites and African-Americans--pointers to risk factors to underlying distribution of tumours in the colorectum. Asian Pac J Cancer Prev 6(3):: 412-419.
7. Li M, Gu J, (2004) Changing patterns of colorectal cancer over the recent two decades in China. Chin J Gastrointest Surg 7(3):: 214-217.
8. Greene FL, Page DL, Fleming ID, (2002) unknown AJCC: cancer staging handbook: From the AJCC cancer staging manual, 6 edn. New York: Springer Verlag.
9. Yang L, Parkin DM, Li LD, Chen YD, Bray F, (2004) Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90(11):: 2157-2166.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):: 2893-2917. doi:10.1002/ijc.25516.
11. Center MM, Jemal A, Ward E, (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18(6):: 1688-1694. doi:10.1158/1055-9965.EPI-09-0090.
12. Ji BT, Devesa SS, Chow WH, Jin F, Gao YT, (1998) Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev 7(8):: 661-666. PubMed: 9718217.
13. Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, et al. (2003) Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 9(11):: 2400-2403.
14. Takada H, Ohsawa T, Iwamoto S, Yoshida R, Nakano M, et al. (2002) Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 45(9):: 1249-1254. doi:10.1007/s10350-004-6400-0.
15. Qing SH, Rao KY, Jiang HY, Wexner SD, (2003) Racial differences in the anatomical distribution of colorectal cancer: a study of differences between American and Chinese patients. World J Gastroenterol 9(4):: 721-725. PubMed: 12679919.
16. Kim DH, Shin MH, Ahn YO, (2000) Incidence pattern of colorectal cancer in Korea by subsite of origin. J Korean Med Sci 15(6):: 675-681. PubMed: 11194194.
17. Sung JJ, Chan FK, Leung WK, Wu JC, Lau JY, et al. (2003) Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 124(3):: 608-614. doi:10.1053/gast.2003.50090.
18. Huang J, Seow A, Shi CY, Lee HP, (1999) Colorectal carcinoma among ethnic Chinese in Singapore: trends in incidence rate by anatomic subsite from 1968 to 1992. Cancer 85(12):: 2519-2525. doi:10.1002/(SICI)1097-0142(19990615)85:12.
19. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H, (2009) Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol 39(3):: 189-191. PubMed: 19164317.
20. Wu X, Chen VW, Martin J, Roffers S, Groves FD, et al. (2004) Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev 13(7):: 1215-1222. PubMed: 15247133.
21. Distler P, Holt PR, (1997) Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 15(4-5):: 302-311. doi:10.1159/000171605.
22. Breivik J, Lothe RA, Meling GI, Rognum TO, Børresen-Dale AL, et al. (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74(6):: 664-669. doi:10.1002/(SICI)1097-0215(19971219)74:6. PubMed: 9421366.
23. McMichael AJ, Potter JD, (1985) Diet and colon cancer: integration of the descriptive, analytic, and metabolic epidemiology. Natl Cancer Inst Monogr 69: 223-228.
24. Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, et al. (2009) Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 27(5):: 663-671. doi:10.1200/JCO.2008.20.8397. PubMed: 19114683.
25. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351(4):: 337-345. doi:10.1056/NEJMoa033025.
26. Tournigand C, André T, Achille E, Lledo G, Flesh M, et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22(2):: 229-237. PubMed: 14657227.
27. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):: 2335-2342. doi:10.1056/NEJMoa032691. PubMed: 15175435.
28. Petrelli NJ, Abbruzzese J, Mansfield P, Minsky B, (2005) Hepatic resection: the last surgical frontier for colorectal cancer. J Clin Oncol 23(20):: 4475-4477. PubMed: 16002836.
29. Pfannschmidt J, Dienemann H, Hoffmann H, (2007) Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 84(1):: 324-338. doi:10.1016/j.athoracsur.2007.02.093.
30. O'Connell JB, Maggard MA, Ko CY, (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96(19):: 1420-1425. doi:10.1093/jnci/djh275.
31. Golan T, Urban D, Berger R, Lawrence YR, (2013) Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location. Cancer (In press).
32. Larsson SC, Rutegård J, Bergkvist L, Wolk A, (2006) Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer 42(15):: 2590-2597. doi:10.1016/j.ejca.2006.04.015. PubMed: 16914307.
33. Steward BW, Kleihues P, (2003) World Cancer Reprot. Lyon: IARC Press. pp. pp. 198-202.
34. Society AC (2007) Global Cancer Facts & Figures. Atlanta, GA: Amercian Cancer Society:pp. 12-3 pp.
35. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):: 1365-1371. doi:10.1056/NEJM199305133281901. PubMed: 8474513.
36. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, et al. (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343(22):: 1603-1607. doi:10.1056/NEJM200011303432203. PubMed: 11096167.
37. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, et al. (2007) Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev 31(1):: 3-11. doi:10.1016/j.cdp.2006.11.002. PubMed: 17289293.
38. Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, et al. (2010) Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Ther 31(3):: 432-439. doi:10.1111/j.1365-2036.2009.04184.x. PubMed: 19878150.
39. van Rossum LG, van Rijn AF, van Munster IP, Jansen JB, Fockens P, et al. (2009) Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests. Neth J Med 67(5):: 182-186. PubMed: 19581668.